INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A.
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A.
Contacts
Registered address
Copy
Website
WWW.BIOMED.PL
A
HighestReliability
A - HighestIncorporation date
18/01/2002Share capital
8,032,700.00 PLNPrimary activity
Manufacture of pharmaceutical preparations (21.20.Z - PKD 2007)Representatives
1Representatives rights
DO SKŁADANIA OŚWIADCZEŃ WOLI I PODPISYWANIA W IMIENIU SPÓŁKI WYMAGANE JEST WSPÓŁDZIAŁANIE DWÓCH CZŁONKÓW ZARZĄDU ALBO JEDNEGO CZŁONKA ZARZĄDU ŁĄCZNIE Z PROKURENTEM.Representatives
Business linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
A*** F*** | Chairman of the management board |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
57,160,766Net Profit (zł)
57,160,766Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 88,544,275 |
| 17,030,736 |
| 10,119,719 |
| 0.73 |
| 10.61 |
| 11.43 |
| 405,251,740 |
| 6,746,264 |
| 45,000 |
| 18,755,060 |
| 2023 |
|---|
| 108,204,590 |
| 46,695,210 |
| 38,150,615 |
| 0.63 |
| 5.41 |
| 35.26 |
| 610,887,736 |
| 15,515,275 |
| 30,000 |
| 20,197,487 |
| 2024 |
|---|
| 127,191,447 |
| 68,081,248 |
| 57,160,766 |
| 0.57 |
| 6.18 |
| 44.94 |
| 698,924,893 |
| 14,000,023 |
| 15,000 |
| - |
| 2024 |
|---|
| 127,191,447 |
| 68,081,248 |
| 57,160,766 |
| 0.57 |
| 6.18 |
| 44.94 |
| 698,924,893 |
| 14,000,023 |
| 15,000 |
| - |
Turnover (zł)
2024
Turnover (zł)
127,191,447 zł
18 % *
Profit before tax (zł)
68,081,248 zł46 % *
Net Profit (zł)
57,160,766 zł50 % *
Working capital requirement (%)
0.57 
-9.52 % *
Liquidity ratio
6.18 14.23 % *
Net profitability (%)
44.94 %27.45 % *
Equity (zł)
698,924,893 zł14 % *
Current liabilities (zł)
14,000,023 zł
-10 % *
Non current liabilities (zł)
15,000 zł-50 % *
Non-current Assets (zł)
-Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A. Documents
Date | Description |
|---|---|
03/07/2025 | OD 01.01.2024 DO 31.12.2024 |
19/06/2024 | OD 01.01.2023 DO 31.12.2023 |
30/06/2023 | OD 01.01.2022 DO 31.12.2022 |
28/07/2022 | OD 01.01.2021 DO 31.12.2021 |
25/06/2021 | OD 01.01.2020 DO 31.12.2020 |